N-3-cyanocyclopentyl-4-(2-(3-amino-phenoxy)ethyl)morpholine | 373826-61-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: N-3-cyanocyclopentyl-4-(2-(3-amino-phenoxy)ethyl)morpholine
• 英文别名: 3-[3-(2-Morpholin-4-ylethoxy)anilino]cyclopentane-1-carbonitrile
• CAS: 373826-61-0
• 化学式: C₁₈H₂₅N₃O₂
• 分子量: 315.415
• InChiKey: WWMIIPCDUSQGIB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  57.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-3-cyanocyclopentyl-4-(2-(3-amino-phenoxy)ethyl)morpholine 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 1-(3-Aminomethyl-cyclopentyl)-1-[3-(2-morpholin-4-yl-ethoxy)-phenyl]-3-phenyl-urea
  参考文献：
  名称：

  Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists

  摘要：

  A series of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives were synthesized as motilin receptor antagonists. Starting from known motilin antagonists, 1a and 1b, the cyclopentene scaffold was replaced and the four recognition elements optimized to arrive at a potent novel series. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.04.017
• 作为产物：
  描述：

  3-氧代环戊烷甲腈 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 N-3-cyanocyclopentyl-4-(2-(3-amino-phenoxy)ethyl)morpholine
  参考文献：
  名称：

  Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists

  摘要：

  A series of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives were synthesized as motilin receptor antagonists. Starting from known motilin antagonists, 1a and 1b, the cyclopentene scaffold was replaced and the four recognition elements optimized to arrive at a potent novel series. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.04.017

文献信息

• Novel substituted diamine derivatives useful as motilin antagonists
  申请人：——

  公开号：US20020013352A1

  公开（公告）日：2002-01-31

  The present invention relates to novel substituted diamine derivatives for the formula 1 wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新型的取代二胺衍生物，其化学式为1，其中R1、R2、R3、R4、X1、X2、X3、X4、A、Y和n如说明书中所述，包含它们的药物组合物以及用于它们制造的中间体。更具体地说，本发明的化合物是莫替林受体拮抗剂，可用于治疗相关疾病和疾病，如胃食管反流疾病、导致肥胖的进食障碍和肠易激综合征。
• Novel substituted diamine derivatives useful as motlin antagonists
  申请人：——

  公开号：US20030203906A1

  公开（公告）日：2003-10-30

  The present invention relates to novel substituted diamine derivatives for the formula 1 wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新的取代二胺衍生物，其化学式为1，其中R1、R2、R3、R4、X1、X2、X3、X4、A、Y和n如规范中所述，以及含有它们的制药组合物和用于制造它们的中间体。更具体地说，本发明的化合物是胃动素受体拮抗剂，可用于治疗相关疾病和疾病，例如胃食管反流病、导致肥胖的进食障碍和肠易激综合征。
• NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTS
  申请人：Johnson G. Sigmond

  公开号：US20070054888A1

  公开（公告）日：2007-03-08

  The present invention relates to novel substituted diamine derivatives for the formula wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新的取代二胺衍生物，其化学式为R1，R2，R3，R4，X1，X2，X3，X4，A，Y和n如规范中所述，包含它们的制药组合物以及用于其制造的中间体。更具体地说，本发明的化合物是莫蒂林受体拮抗剂，可用于治疗相关疾病和疾病，如胃食管反流疾病，导致肥胖的进食障碍和肠易激综合征。
• SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS
  申请人：Ortho-McNeil Pharmaceutical, Inc.

  公开号：EP1294695A2

  公开（公告）日：2003-03-26
• US6511980B2
  申请人：——

  公开号：US6511980B2

  公开（公告）日：2003-01-28